Extent of damage and repair in the p53 tumor-suppressor gene after treatment of myeloma patients with high-dose melphalan and autologous blood stem-cell transplantation is individualized and may predict clinical outcome
Extent of damage and repair in the p53 tumor-suppressor gene after treatment of myeloma patients with high-dose melphalan and autologous blood stem-cell transplantation is individualized and may predict clinical outcome
Languages of Item:
English
Abstract:
Empty abstract
Publication year:
2005
Authors:
Dimopoulos, Meletios A Souliotis, Vassilis L Anagnostopoulos, Athanasios Papadimitriou, Christos Sfikakis, Petros P
